Default company panoramic image
Logo

ReNeu Inc.

ReNeu Inc. is a Canadian-based biotechnology company developing novel therapies for the treatment of central nervous system disorders.

  • Stage Product In Development
  • Industry Healthcare Services
  • Location Calgary, AB, Canada
  • Currency CAD
  • Website reneuinc.com

Company Summary

Our approach enhances brain remodeling and plasticity by administering neurogenesis-promoting drugs directly into the brains of patients. Our lead program aims to improve brain and motor function in victims of stroke. ReNeu was formed as a joint venture: our technology combines the clinically advanced neurogenesis-promoting drugs developed by Stem Cell Therapeutics (TSX:SSS) with the FDA-cleared intracranial delivery systems of NexGen Medical.

Team

  • Default avatar
    Joseph Tucker
    CEO

    Formerly:
    CFO SolAeroMed Inc.
    CEO Pharmavation Inc.
    CEO Stem Cell Therapeutics (TSX:SSS)
    VP Resverlogix (TSX:RVX)
    VP Neurostasis (sold to TSX:TTH)
    Healthcare Analyst (Acumen Capital)
    PhD (UofCalgary, Molecular Biology)

Advisors

  • Default avatar
    Michael Flach, Norton Rose, Calgary
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    Founders
    Unconfirmed